NCT03234660View on ClinicalTrials.gov

Dexmedetomidine and Neuroprotection in Children Undergoing General Anesthesia

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

October 5, 2019

Study Completion Date

October 5, 2019

Conditions
Dexmedetomidine
Interventions
DRUG

Dexmedetomidine Hydrochloride

dexmedetomidine 1mcg/kg loading and 0.5mcg/kg/hr continuous infusion during surgery

OTHER

control

0.9% normal saline continuous infusion

Trial Locations (1)

15710

SNUH, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT03234660 - Dexmedetomidine and Neuroprotection in Children Undergoing General Anesthesia | Biotech Hunter | Biotech Hunter